Betaine as a Determinant of Postmethionine Load Total Plasma Homocysteine before and after B-Vitamin Supplementation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 2, 2004, Pages 301-307

  Holm, Päl I ^a   Bleie, Øyvind ^a   Ueland, Per M ^a   Lien, Ernst A ^a   Refsum, Helga ^b   Nordrehaug, Jan E ^a   Nygård, Ottar ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Betaine; Folate; Homocysteine; Vitamin B12; Vitamin B6

Indexed keywords

BETAINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHYLTRANSFERASE; PLACEBO; PYRIDOXINE; VITAMIN B GROUP;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BETAINE; CHOLINE; CORONARY ANGIOGRAPHY; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; METHYLTRANSFERASES; MIDDLE AGED; SARCOSINE; SEX FACTORS; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 1042268029     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000114569.54976.31     Document Type: Article

References (39)

1. Clarke R, Collins R, Lewington S, Donald A, Alfthan G, Tuomilehto J. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015-2022.
2. Carmel R, Jacobsen DW. Homocysteine Health and Disease. Cambridge, New York, Melbourne. Madrid. Cape Town: Cambridge University Press: 2001.
3. Ueland PM, Refsum H, Schneede J. Determinants of plasma homocysteine. In: Robinson K. ed. Homosysteine and Vascular Disease. Dordrecht, Boston. London: Kluwer Academic Publishers; 2000.
4. Jacques PF, Boston AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613-621.
5. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1:228-237.
6. Franken DG, Boers GH, Blom HJ, Trijbels JM. Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocystinemia in vascular patients. J Inherit Metab Dis. 1994;17:159-162.
7. Dierkes J, Kroesen M, Pietrzik K. Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women. Int J Vitam Nutr Res. 1998;68:98-103.
8. McKinley MC, McNulty H, McPartlin J, Strain JJ, Pentieva K, Ward M, Weir DG, Scott JM. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr. 2001;73:759-764.
9. de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocystinemia and premature vascular disease. Arterioscler Thromb Vasc Biol. 1999;19:1316-1324.
10. Ubbink JB, Becker PJ, Delport R, Bester M, Riezler R, Vermaak WJ. Variability of post-methionine load plasma homocysteine assays. Clin Chim Acta. 2003;330:111-119.
11. Graham IM, Daly LE, Refsum H, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelsson B, Ulterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA. 1997;277:1775-1781.
12. Miller JW, Nadeau MR, Smith D, Selhub J. Vitamin B-6 deficiency vs. folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr. 1994;59:1033-1039.
13. Zeisel SH. Choline: An essential nutrient for humans. Nutrition. 2000;16:669-671.
14. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis. 1997;20:295-300.
15. Brouwer IA, Verhoef P, Urgen R. Betaine supplementation and plasma homocysteine in healthy volunteers. Arch Intern Med 2000;160:2546-2547.
16. Steenge GR, Verhoef P, Olthof MR, Katan MB. Effect of betaine on plasma concentrations of fasting and post-methionine loading homocysteine in healthy volunteers. Abstract 257. 3rd International Conference on Homocysteine Metabolism, July 1-5. Sorrento, Naples. 2001.
17. Schwab U, Torronen A, Toppinen L, Alfthan G, Saarinen M, Aro A, Uusitupa M. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr. 2002;76:961-967.
18. Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr. 2003;133:1291-1295.
19. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler. Thromb. 1993;13:1253-1260.
20. McGregor DO, Dellow WJ, Robson RA, Lever M, George PM, Chambers ST. Betaine supplementation decreases post-methionine hyperhomocystinemia in chronic renal failure. Kidney Int. 2002;61:1040-1046.
21. Schwahn BC, Chen Z, Laryea MD, Wendel U, Lussier-Cacan S, Genest J, Jr., Mar MH, Zeisel SH, Castro C, Garrow T, Rozen R. Homocysteine-betaine interactions in a murine model of 5, 10-methylenetetrahydrofolate reductase deficiency. FASEB J. 2003;17:512-514.
22. Hohn PI, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem. 2003;49:286-294.
23. Husek P. Chloroformates in gas chromatography as general purpose derivatizing agents. J Chromatogr B Biomed Sci Appl. 1998;717:57-91.
24. Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol. 1991;44:592-595.
25. O'Broin S, Kelleher B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol. 1992;45:344-347.
26. Bor MV, Refsum H, Bisp MR, Bleie O, Schneede J, Nordrehaug JE, Ueland PM, Nygard OK, Nexo E. Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study. Clin Chem. 2003;49:155-161.
27. Nexo E, Hvas AM, Bleie O, Refsum H, Fedosov SN, Vollset SE, Schneede J, Nordrehaug JE, Ueland PM, Nygard OK. Holotranscobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem. 2002;48:1768-1771.
28. Allen RH, Stabler SP, Lindenbaum J. Serum betaine N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism. 1993;42:1448-1460.
29. Lever M, Sizeland PC, Bason LM, Hayman CM, Robson RA, Chambers ST. Abnormal glycine betaine content of the blood and urine of diabetic and renal patients. Clin Chim Acta. 1994;230:69-79.
30. Park EI, Garrow TA. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem. 1999;274:7816-7824.
31. Eckernas SA, Aquilonius SM. Free choline in human plasma analysed by simple radio-enzymatic procedure: age distribution and effect of a meal. Scand J Clin Lab Invest. 1977;37:183-187.
32. Savendahl L, Mar MH, Underwood LE, Zeisel SH. Prolonged fasting in humans results in diminished plasma choline concentrations but does not cause liver dysfunction. Am J Clin Nutr. 1997;66:622-625.
33. McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001;59:2267-2272.
34. Wilcken DEL, Wilcken B, Dudman NPB, Tyrrell P. A. Homocystinuria: the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med. 1983;309:448-453.
35. Wendel U, Bremer HJ. Betaine in the treatment of homocystinuria due to 5, 10-methyleneletrahydrofolate reductase deficiency. Eur J Pediatr. 1984;142:147-150.
36. Holme E, Kjellman B, Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child. 1989;64:1061-1064.
37. Emmert JL, Garrow TA, Baker DH. Hepatic betaine-homocysteine methyltransferase activity in the chicken is influenced by dietary intake of sulfur amino acids, choline and betaine. J Nutr. 1996;126:2050-2058.
38. Park EI, Renduchintala MS, Garrow TA. Diet-induced changes in hepatic betaine-homocysteine methyltransferase activity are mediated by changes in the steady-state level of its mRNA. J Nutr Biochem. 1997;8:541-545.
39. Emmert JL, Webel DM, Biehl RR, Griffiths MA, Garrow LS, Garrow TA, Baker DH. Hepatic and renal betaine-homocysteine methyltransferase activity in pigs as affected by dietary intakes of sulfur amino acids, choline, and betaine. J Animal Sci. 1998;76:606-610.